PATENT CLAIM ANALYSIS

Application Number: 15959379
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy in the treatment of neurodegenerative disorders, in particular axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases including glaucoma.

Claim (Index 3):
The method of  claim 2 , wherein said pharmaceutical composition further comprises one or more compounds selected from the group consisting of nicotinamide mononucleotide (NMN), pyrroloquinoline quinone (PQQ), nicotinamide adenine dinucleotide (NAD) and nicotinamide ribose (NR).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11144358', '14511701', '14434573', '15632106', '12563483']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7928334845923178
- 35 USC 102 Novelty (BERT): 0.513459555622033
- Combined Prediction Score: 0.7648960916952894
- Mean Citation Score: 271.268122
- Max Citation Score: 301.51733
- Similarity Product: 221.29467827180684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test